Emily R. Gabranski focuses her practice on patent litigation, primarily in the biotechnology and pharmaceutical areas. She assists with Hatch-Waxman litigation related to Abbreviated New Drug Applications (ANDA) and post-grant proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO).
Prior to joining Finnegan, Emily conducted research in cellular and molecular neurobiology. Her research focused on transmitter modulation of neuronal network interactions. She coauthored two peer-reviewed publications in scientific journals and presented her research at the Society for Neuroscience annual meeting.
While in law school, Emily worked as a summer associate at Finnegan, where she assisted in litigation matters before the PTAB and federal district courts. She also worked in the Vanderbilt Intellectual Property Clinic, assisting clients with USPTO filings and state trademark registration.
Vanderbilt University J.D., 2015
Bowdoin College B.A., Neuroscience, with honors, 2009